RxDoctor Payments Data

Amber Ream, NP

Nurse Practitioner · Mansfield, OHNPI 1912370883

Payments from drug & device makers

$518in general payments, 2019–2025

Across 21 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$256
  • Medtronic$102
  • AstraZeneca$41
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$41
  • E.r. Squibb & Sons, L.L.C.$23
  • Boehringer Ingelheim$20
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$46490%
  • Education$5410%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$518 in reported general payments places this provider in the 75th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$38,489
Medicare patients
315
Services billed
557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban347$331,118
XareltoRivaroxaban46$48,879
Dofetilide148$23,311
BrilintaTicagrelor25$14,994
Flecainide Acetate144$5,597
Mexiletine Hcl51$4,506
Metoprolol Succinate335$3,995
Amiodarone Hcl181$2,274
Diltiazem 24hr Er (Cd)Diltiazem Hcl70$1,628
SotalolSotalol Hcl78$1,171
Potassium Chloride78$1,045
Metoprolol Tartrate86$424
Klor-Con M20Potassium Chloride23$417
Sucralfate22$404
Carvedilol28$316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$41$14,99425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Mansfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →